Arcinova have established expertise and technologies that are routinely applied to the understanding of active pharmaceutical ingredients (APIs), how best to formulate them for clinical and non-clinical applications, what their stability characteristics are and how to manufacture the formulations of choice reproducibly.
Formulation development programs can be conducted in isolation but are most powerful when combined with some or all of the synthetic, analytical, microbiological, clinical product manufacturing and regulatory CMC expertise available within Arcinova.
Our range of services related to drug product include:
• Materials science and spectroscopic investigations
• Non-clinical formulation development (oral and IV)
• Clinical formulation development (oral and IV)
• Stability testing
• Clinical Product Manufacture (oral and IV)
• Clinical product manufacture (Cytotoxic/high potency/radiolabelled products)
• QC testing and QP release
CED Life ScienceThe CED Life Science Conference will be attended by Masha Kononov, Senior Director Emerging Pharma US and Gail Frey, Senior Director Key Accounts US.
CED Life ScienceDates: 26th - 27th FebruaryLocation: Raleigh, NC
Drug Delivery & Formulation SummitThe DDF Summit 2019 will be attended by Dr. Nathalie Huther, Business Development Manager Europe.
Drug Delivery & Formulation SummitDates: 11th - 13th MarchLocation: Berlin, Germany
BioEurope SpringBioEurope Spring will be attended by Dr. Nathalie Huther, Business Development Manager Europe.
BioEurope SpringDates: 25th - 27th MarchLocation: Vienna, Austria